Professor Jarad Martin
MBChB BSc PhD DMed, FRANZCR GAustMS, Radiation Oncologist
I have had a long interest in health, technology and mathematics. All of this comes together in the field of Radiation Oncology.
Prostate, bladder, rectal, anal, gastrointestinal cancers, Dupuytren’s disease, Ledderhose disease and benign conditions.
Special clinical interest in prostate, bladder, rectal, anal, gastrointestinal cancers, Dupuytren’s disease, Ledderhose disease and benign conditions.
Prof. Jarad Martin is a radiation oncologist with strong research interests. He sub-specialises in the multidisciplinary management of gastrointestinal tumours (including tumours of the rectum and anal canal) as well as genitourinary malignancies (including prostate and bladder cancers). A more recent interest is the use of low dose radiotherapy for conditions such as plantar fasciits, Dupuytren’s and Ledderhose diseases.
Jarad attends and contributes to the Newcastle multidisciplinary meetings discussing patients with all of these disease, and has a leading role in helping organise specialist education events in the Hunter region. His technical knowledge is well recognised in areas including intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT) and stereotactic radiotherapy (SBRT). Having worked in Victoria, Queensland and Canada prior to commencing practice in Newcastle, he is able to bring a broad perspective to his management of people with cancer.
Jarad has authored more than 100 peer reviewed publications, being awarded more than $12 Million in competitive research funding and has won awards in both Canada and Australasia recognising the quality of his research. He has held senior positions in several national bodies including the Trans-Tasman Radiation Oncology Group, for whom he was the convenor for their 2015 Annual Scientific Meeting.
- Chris Atkinson Award for Best Scientific Paper: Faculty of Radiation Oncology Annual Scientific Meeting, July 2012
- Orchid prize: Trans-Tasman Radiation Oncology Group for best new trial proposal at Annual Scientific Meeting 2007
- ‘Evidence Based follow-up of stage one seminoma’
- American Society of Clinical Oncology Merit Award 2006
- Canadian Young Oncology Investigator of the Year Award 2006
- ‘Hypofractionated radiotherapy for prostate cancer’ – Ray Bush prize for best Radiation Oncology fellow research Princess Margaret Hospital, Toronto 2006
Professor Martin is the lead investigator for the DEPART trial studying the efficacy or radiotherapy in Dupuytren’s disease. He is also a co-lead investigator for the NINJA study, comparing two shorter courses of radiotherapy for men with prostate cancer.